Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Responder analysis using clinically meaningful thresholds: Post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis.
Kwatra SG, Yosipovitch G, Ständer S, Guillemin I, Msihid J, Bansal A, Makhija M, Wiggins S, Zahn J, Thomas RB, Bahloul D. Kwatra SG, et al. Among authors: stander s. J Eur Acad Dermatol Venereol. 2024 May 24. doi: 10.1111/jdv.20099. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38785405
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
Ständer S, Pereira MP, Zeidler C, Legat FJ, Misery L, Lönndahl L, Bewley AP, Brenaut E, Bobko S, Elberling J, Evers AWM, Garcovich S, Gieler U, Gonçalo M, Kupfer J, Lambert J, Lvov A, Metz M, Michenko A, Papadavid E, Reich A, Savk E, Schneider G, Schut C, Serra-Baldrich E, Ständer HF, Szepietowski JC, Wallengren J, Weisshaar E, Augustin M. Ständer S, et al. J Eur Acad Dermatol Venereol. 2024 May 13. doi: 10.1111/jdv.20102. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38738586
Chronic nodular prurigo: Association between comorbidities, itch and quality of life.
Pereira MP, Gutsche A, Weisshaar E, Halvorsen JA, Wallengren J, Legat FJ, Garcovich S, Savk E, Reich A, Bozek A, Lvov A, Bobko S, Metz M, Streit M, Misery L, Brenaut E, Serra-Baldrich E, Goncalo M, Szepietowski JC, Augustin M, Zeidler C, Ständer S. Pereira MP, et al. Among authors: stander s. J Eur Acad Dermatol Venereol. 2024 May 13. doi: 10.1111/jdv.20038. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38736376 No abstract available.
Chronic Prurigo.
Thünemann J, Müller S, Steinbrink K, Ständer S, Zeidler C. Thünemann J, et al. Among authors: stander s. J Dtsch Dermatol Ges. 2024 May 9. doi: 10.1111/ddg.15317. Online ahead of print. J Dtsch Dermatol Ges. 2024. PMID: 38722190
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
Simpson EL, Prajapati VH, Leshem YA, Chovatiya R, de Bruin-Weller MS, Ständer S, Pink AE, Calimlim BM, Lee WJ, Teixeira H, Ladizinski B, Hu X, Yang Y, Liu Y, Liu M, Grada A, Platt AM, Silverberg JI. Simpson EL, et al. Among authors: stander s. Dermatol Ther (Heidelb). 2024 May;14(5):1127-1144. doi: 10.1007/s13555-024-01157-5. Epub 2024 May 2. Dermatol Ther (Heidelb). 2024. PMID: 38696027 Free PMC article.
Validation of a scoring algorithm for the clinician-reported outcome tool 'prurigo activity and severity (PAS)' based on clinical studies of dupilumab in adults with prurigo Nodularis.
Zeidler C, Stander S, Rhoten S, Wratten S, Zhang D, Msihid J, Brookes E, Thomas R, Bahloul D. Zeidler C, et al. Among authors: stander s. J Eur Acad Dermatol Venereol. 2024 Apr 2. doi: 10.1111/jdv.19961. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38563058
487 results